Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer.

Phase II trial of weekly intravenous gemcitabine with continuous infusion fluorouracil in patients with metastatic renal cell cancer. J Clin Oncol. 2000 Jun; 18(12):2419-26.

View in: PubMed

subject areas

Adult
Aged
Aged, 80 and over
Antineoplastic Combined Chemotherapy Protocols
Carcinoma, Renal Cell
Deoxycytidine
Disease-Free Survival
Drug Administration Schedule
Female
Fluorouracil
Humans
Infusions, Intravenous
Kidney Neoplasms
Male
Middle Aged
Treatment Outcome

authors with profiles

Walter M. Stadler